Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-09-28

Clinical Trial Update: Multimodal Analgesia in Shoulder Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 trial on multimodal analgesia for shoulder arthroplasty was withdrawn from development.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rush University Medical Center | Conditions: Shoulder Pain, Opioid Use | Phase 3 | Status: WITHDRAWN